Modified drug release refers to the strategic alteration of the release kinetics of a pharmaceutical compound within the body, aiming to optimize therapeutic outcomes while minimizing adverse effects. This approach encompasses a variety of techniques and formulations designed to exert control over the timing, rate, and location of drug delivery. One common strategy involves the development of sustained-release formulations, where the drug is released gradually over an extended period, maintaining therapeutic concentrations in the bloodstream and thereby reducing the frequency of dosing. These formulations often employ specialized drug delivery systems such as hydrogels, liposomes, or microspheres, which encapsulate the active ingredient and control its release through diffusion, erosion, or other mechanisms.
Another approach to modified drug release involves targeting specific sites or tissues within the body to enhance efficacy and reduce systemic side effects. This can be achieved through the use of targeted drug delivery systems that exploit physiological or pathological characteristics of the target tissue, such as pH, temperature, or enzymatic activity. By encapsulating the drug within carriers that selectively release their cargo in response to these cues, researchers can achieve site-specific drug delivery, maximizing therapeutic effects while minimizing off-target effects.
In addition to sustained-release and targeted delivery approaches, modified drug release can also involve the use of novel drug delivery routes and technologies. For example, transdermal patches and implants allow for continuous and controlled release of drugs through the skin or implanted devices, offering advantages such as improved patient compliance and reduced dosing frequency. Similarly, advances in nanotechnology have enabled the development of nanoscale drug delivery systems capable of crossing biological barriers and delivering drugs to specific cellular targets, opening up new possibilities for personalized medicine and precision therapeutics.
Title : Enhancing process efficiency and safety with advanced sensor technology
Susanne Naf Rudiger, Hamilton Bonaduz AG, Switzerland
Title : Solar box cooker dehydration, and relative humidity endpoint detection, of lamiaceae culinary leaves on the island of Crete
Victor John Law, Technical University Dublin, Ireland
Title : Photoaligned azodye nanolayers: New nanotechnology for liquid crystal display and photonics devices
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign-inspired and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Utilizing generative AI for interactive borane modeling: Insights from Wade's rule in undergraduate education
Mai Yan Yuen, The University of Hong Kong, Hong Kong
Title : Utilisation of optical spectroscopy and physical chemistry methods in studies of interaction between pesticide molecules and vital bio-macromolecules
Jana Stanicova, Charles University, Czech Republic